BMT Stock Overview
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Beamtree Holdings Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.17 |
52 Week High | AU$0.34 |
52 Week Low | AU$0.16 |
Beta | 1.75 |
1 Month Change | -19.05% |
3 Month Change | -26.09% |
1 Year Change | -40.35% |
3 Year Change | -59.52% |
5 Year Change | n/a |
Change since IPO | -8.11% |
Recent News & Updates
Recent updates
Shareholder Returns
BMT | AU Healthcare Services | AU Market | |
---|---|---|---|
7D | -2.9% | 4.7% | 0.9% |
1Y | -40.4% | 57.6% | 5.6% |
Return vs Industry: BMT underperformed the Australian Healthcare Services industry which returned 57.6% over the past year.
Return vs Market: BMT underperformed the Australian Market which returned 5.6% over the past year.
Price Volatility
BMT volatility | |
---|---|
BMT Average Weekly Movement | 10.2% |
Healthcare Services Industry Average Movement | 8.1% |
Market Average Movement | 8.9% |
10% most volatile stocks in AU Market | 17.6% |
10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: BMT's share price has been volatile over the past 3 months.
Volatility Over Time: BMT's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 95 | Tim Kelsey | beamtree.com.au |
Beamtree Holdings Limited develops and commercializes clinical decision support (CDS) systems to healthcare industry in Australia and internationally. The company offers RippleDown Expert, a CDS system that provides real-time patient monitoring and alerting solutions; RippleDown Auditor, that automates real-time reviews of data, ensuring accuracy across data entry, billing, specimen reception, and flagging suspected errors; and PICQ, a coding quality assessment tool for public and private hospitals, health services, and state health departments that assesses and reports clinically coded data. It also provides RISQ, a measurement, benchmarking, and management tool for hospital-acquired complications; Q Coding Platform, an end-to-end workflow suite for clinical coding, grouping, reporting, and auditing; and Codexpert, a searchable eBook application that offers classification reference information for clinical coding patient records.
Beamtree Holdings Limited Fundamentals Summary
BMT fundamental statistics | |
---|---|
Market cap | AU$48.87m |
Earnings (TTM) | -AU$5.68m |
Revenue (TTM) | AU$25.22m |
1.9x
P/S Ratio-8.6x
P/E RatioIs BMT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BMT income statement (TTM) | |
---|---|
Revenue | AU$25.22m |
Cost of Revenue | AU$21.89m |
Gross Profit | AU$3.33m |
Other Expenses | AU$9.01m |
Earnings | -AU$5.68m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.02 |
Gross Margin | 13.19% |
Net Profit Margin | -22.54% |
Debt/Equity Ratio | 1.1% |
How did BMT perform over the long term?
See historical performance and comparison